Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. - Wikidata - wikimedia - TriplyDB

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

http://www.wikidata.org/entity/Q40350054

about

Tumor metastasis to bone Osteoblasts Are the Centerpiece of the Metastatic Bone Microenvironment BMP-7 enhances cell migration and αvβ3 integrin expression via a c-Src-dependent pathway in human chondrosarcoma cells Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone Regulation of phosphatase homologue of tensin protein expression by bone morphogenetic proteins in prostate epithelial cells.BMP7: a new bone metastases prevention?Androgen receptor-negative human prostate cancer cells induce osteogenesis in mice through FGF9-mediated mechanisms.A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions.Prostate cancer derived prostatic acid phosphatase promotes an osteoblastic response in the bone microenvironment.Characterization of osteoblastic and osteolytic proteins in prostate cancer bone metastases.Bone morphogenetic protein 7 is expressed in prostate cancer metastases and its effects on prostate tumor cells depend on cell phenotype and the tumor microenvironment.Bone metastasis: mechanisms and therapeutic opportunities.Combined inhibition of the BMP pathway and the RANK-RANKL axis in a mixed lytic/blastic prostate cancer lesion The host microenvironment influences prostate cancer invasion, systemic spread, bone colonization, and osteoblastic metastasis.Applications of immunoPET: using 124I-anti-PSCA A11 minibody for imaging disease progression and response to therapy in mouse xenograft models of prostate cancer.Breast cancer cells induce osteolytic bone lesions in vivo through a reduction in osteoblast activity in mice.BMP-2 promotes oral squamous carcinoma cell invasion by inducing CCL5 release.Lack of noggin expression by cancer cells is a determinant of the osteoblast response in bone metastases.The Wnt inhibitor dickkopf-1: a link between breast cancer and bone metastases.Bone matrix osteonectin limits prostate cancer cell growth and survival.Bone morphogenetic protein modulator BMPER is highly expressed in malignant tumors and controls invasive cell behavior.The IGR-CaP1 xenograft model recapitulates mixed osteolytic/blastic bone lesions observed in metastatic prostate cancer Wnt inhibitory factor 1 (Wif1) is regulated by androgens and enhances androgen-dependent prostate development.Combination therapy with BMP-2 and a systemic RANKL inhibitor enhances bone healing in a mouse critical-sized femoral defect.Influence of simultaneous targeting of the bone morphogenetic protein pathway and RANK/RANKL axis in osteolytic prostate cancer lesion in bone.Bone morphogenetic proteins and cancer: review of the literature.Steps in prostate cancer progression that lead to bone metastasis Follistatin as potential therapeutic target in prostate cancer.Signaling between tumor cells and the host bone marrow microenvironment.Use of recombinant human bone morphogenetic protein-2 in spine surgery.A Review of the Clinical Side Effects of Bone Morphogenetic Protein-2.Bone morphogenetic protein signaling in musculoskeletal cancer.Galectin-3 in bone tumor microenvironment: a beacon for individual skeletal metastasis management.Prostate cancer cells and bone stromal cells mutually interact with each other through bone morphogenetic protein-mediated signals.BMP4 promotes prostate tumor growth in bone through osteogenesis.Effects of the bone morphogenetic protein binding protein spp24 (secreted phosphoprotein 24 kD) on the growth of human lung cancer cells.Bone morphogenetic protein-7 is a MYC target with prosurvival functions in childhood medulloblastoma.Development of an in vitro model to study the impact of BMP-2 on metastasis to bone.Prostate cancer cells modulate osteoblast mineralisation and osteoclast differentiation through Id-1.BMP-2 signaling in ovarian cancer and its association with poor prognosis.

P2860

Q21195416-413D12EA-109A-4409-9725-7D6CEE41C009 Q28077461-2458A631-5207-4362-AC85-11092C950FF2 Q28544902-F2B62CBE-5E29-462C-9809-D36774BE0BEA Q28593008-3E3A88DF-9760-4CF6-8B2B-86CC7764BB44 Q30426736-1047D7D8-D7B2-4E9B-8CCD-5A8E4075098E Q30443506-2ACC09EB-6630-4E6E-A480-A072E41C0A47 Q30482634-A02DAC7B-331E-4938-B93E-31E2AD707244 Q30504566-3894F4BD-E4B4-46C8-8866-62FF89575443 Q30573685-AA7FA704-BF21-4083-BA7A-E3F04C841B62 Q30596578-5D9E38CE-5A5F-4619-857F-2310EFE1F119 Q33622608-1EFB0B99-0EBC-48B2-A2F3-9BC06488997E Q34025195-F89380DF-C5D6-4507-BF5D-2398A6401AF2 Q34574593-FA3696D9-02D2-48F2-BA15-AD393134A8A6 Q34699785-EA29DDBC-BDDC-4075-8FAC-0F3E51AE26F3 Q34717742-071B0C03-0A47-4EEC-90CF-EDC662C3362A Q34998432-D33F555F-7FF5-4B19-BA71-C9E826A57025 Q35290842-78499017-AE27-456B-A507-FAE72E9F48BB Q35570431-379A9935-3290-4833-8619-27A0921987DD Q35792851-4896F4C8-638B-49E8-8A53-FBE189218084 Q36007768-5C1C545B-4902-4641-BC88-E6DF9DBC54FB Q36035290-667F050E-3C36-4147-94E7-6A92A425D0E9 Q36062138-3D2D521C-6D5F-429A-B2CB-80797D766C4F Q36439567-FF713600-7FCC-4BAC-AF54-6756ADE25BC6 Q36994965-011BC16C-D124-427F-BC1D-8E411B49AE25 Q37131738-DCE95540-CA9C-42C2-9F3D-427FBB109AE2 Q37665275-C31C5E43-7E7B-4D10-AD08-10180D90B4AE Q37848782-72F2EF72-C1C0-46D8-BA15-4C04842F1EF2 Q38086102-3C7CE875-233C-4208-9A62-B2B3D1D714EA Q38138849-C7EF70BA-DED8-4C1C-9394-3119E8462B57 Q38624760-C99F1396-BFE3-496A-89D8-9BB041DFA147 Q38726586-8469E538-7BF0-480A-A1A2-D56B8EA5AFFC Q38797636-1DA15BB4-E79B-4A1F-85B6-25B1C76A4A1E Q38805260-8E3EABED-296E-4940-ABE8-06BEB1BE126B Q39359077-E79E898C-B6CE-4496-B600-C2A713CF5C55 Q39525268-CE245FF0-6B2B-40CC-838E-38932EDE41C2 Q39555278-649DC992-E277-4915-8266-13E24C227884 Q39593013-488E93E9-1952-4256-81A2-E85F434B93C2 Q39652024-2B05B128-5429-43FF-AE22-FD9606C02FD5 Q39763199-52E8FD70-1FC4-474F-8F1D-9DF073A384E1 Q39861127-CE4C982E-57BB-47FA-BA1F-3299C8546F99

P2860

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

http://www.wikidata.org/entity/Q40350054

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

2005年论文

@zh

2005年论文

@zh-cn

name

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

@en

type

label

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

@en

prefLabel

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

@en

P1433

Q40350054-71D508A8-1F60-443D-BDFF-103EAF7710E6

P1476

Q40350054-E5746FDA-7440-46ED-A0CA-C117DD377AC6

P2093

Q40350054-2F99F635-83BF-4EC5-9319-159E15F1263E

Q40350054-5B1F338E-76F1-4D63-9E94-058E11F6C426

Q40350054-6B65F62B-3FF5-4E77-A395-E5104F398548

Q40350054-6D305EB0-3F43-4C0E-A511-0DE0D6FA848D

Q40350054-A5432870-A78D-485B-9188-2DF5F3CE77BD

Q40350054-A850F75B-AC02-4840-981A-B79DAB227754

Q40350054-CA569A0B-B148-4468-A86C-41EFA72ACFB0

Q40350054-F93AC017-0CDB-4C7C-B545-281E6F1C8311

P2860

Q40350054-1A98521A-FCA1-4D89-AD6C-FFFB5F31524B

Q40350054-3A31CCD2-90D6-4BDF-8DD3-83FB80238982

Q40350054-5BB02EBE-C8CF-4E97-95EF-88DC8CA050D7

P304

Q40350054-2FC9BA21-4727-4031-BB07-F921E5B7D957

P31

Q40350054-3183BAFA-22AD-40B6-A04A-20B2B2A2A78E

P356

Q40350054-674DCCE1-59F5-4BF8-9DD0-B715051AF4B7

P433

Q40350054-FA2BEB0C-850E-4295-BAA4-C9826D8F19EA

P478

Q40350054-F858146D-F2EF-45D4-B995-D6B6D97D0E25

P577

Q40350054-F09B316D-59D0-4FE6-AF95-CAEBAD73C13C

P698

Q40350054-B401D12D-05AD-4A29-98F1-F26CA94D27D3

P356

P1433

Journal of Bone and Mineral Research

P1476

Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.

@en

P2093

Brian T Feeley

http://www.w3.org/2001/XMLSchema#string

Jay R Lieberman

http://www.w3.org/2001/XMLSchema#string

Johnny Huard

http://www.w3.org/2001/XMLSchema#string

Lucie Krenek

http://www.w3.org/2001/XMLSchema#string

Nancy Liu

http://www.w3.org/2001/XMLSchema#string

Paul Robbins

http://www.w3.org/2001/XMLSchema#string

Seth C Gamradt

http://www.w3.org/2001/XMLSchema#string

Wellington K Hsu

http://www.w3.org/2001/XMLSchema#string

P2860

Bone morphogenetic protein receptor complexes on the surface of live cells: a new oligomerization mode for serine/threonine kinase receptors

Human type II receptor for bone morphogenic proteins (BMPs): extension of the two-kinase receptor model to the BMPs

Synergistic enhancement of bone formation and healing by stem cell-expressed VEGF and bone morphogenetic protein-4.

P304

2189-2199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1359/JBMR.050802

http://www.w3.org/2001/XMLSchema#string

P433

12

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2005-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16294272

http://www.w3.org/2001/XMLSchema#string